Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers

Inclusion Criteria: * Team member at Hackensack Meridian Health * Age: 18+ * Willing to provide informed consent * Formal diagnosis of COVID-19 via Polymerase Chain Reaction (PCR)test (if home test was done, team member must confirm via PCR test) * Outpatient treatment only for covid-19; no hospitalization (most team members will be vaccinated and may likely have milder case) * Must be experiencing 1+ ongoing covid-19 symptom being measured in this study (respiratory symptoms (shortness of breath, cough), fatigue, loss of taste, loss of smell) * Symptom(s) have persisted for more than 12 weeks after initial infection * Symptom(s) coincided with covid-19 infection and were not present prior to covid-19 infection * Does not have soy allergy * Does not have allergy to fish * Able to participate in bi-weekly surveys in Research Electronic Data Capture (REDCap) * Able to take own blood pressure and record it in bi-weekly REDCap survey * Willing to participate in 12-week study and be assigned to either intervention or placebo arm * Not currently taking an omega-3 supplement or other high-dose supplement (over 2,000 IU) with potential for aiding recovery of long covid syndrome (e.g. zinc, Vit C, Elderberry). * Able to take/swallow six mini-pills daily * Able and willing to give a spot blood sample (2 drops) at baseline and end of study. Exclusion Criteria: * Not a Team Member at Hackensack Meridian Health * Not age 18+ * Unwilling to provide informed consent/ declined to take part * No formal diagnosis of COVID-19 via PCR test (if home test was done, team member must confirm via PCR test) * Were hospitalized for treatment of covid-19 * Not experiencing 1+ ongoing covid-19 symptom being measured in this study (respiratory symptoms (shortness of breath, cough), fatigue, loss of taste, loss of smell) * Symptom(s) have persisted for more than 12 weeks after initial infection * Symptom(s) did not coincide with covid-19 infection and were present prior to covid-19 infection * Does have soy allergy * Does have allergy to fish * Not able to participate in bi-weekly surveys in REDCap * Able to take own blood pressure and record it in bi-weekly REDCap survey * Not willing to participate in 12-week study and be assigned to either intervention or placebo arm * Currently taking an omega-3 supplement or other high-dose supplement (over 2,000 IU) with potential for aiding recovery of long covid syndrome (e.g. zinc, Vit C, Elderberry). * Unable to take/swallow six mini-pills daily * Not able and not willing to give a spot blood sample (2 drops) at baseline and end of study.